ACADIA PHARMACEUTICALS INC

By person

14 insiders · 24 transactions

0.4×

Catherine Owen holds only 0.4 times base salary in stock. $434.28K of shares against $930.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Catherine Owen last reported holding, valued at $29.34, the price Common Stock was last bought or sold at on the open market here, on 6 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

—

$1.13M (9) scheduled

−$1.13M

67,828

0.0394%

$1.99M

+44.0%

Daly James M

Director

—

$670.98K (1)

−$670.98K

12,148

0.0071%

$356.39K

−50.7%

Kihara James

PRINCIPAL ACCOUNTING OFFICER

—

$602.84K (8) scheduled

−$602.84K

13,088

0.0076%

$383.97K

−29.1%

Thompson Elizabeth H.Z.

EVP, Head of Research & Dev

—

$506.41K (3)

−$506.41K

18,994

0.0110%

$557.24K

—

Owen Adams Catherine

Chief Executive Officer

—

$249.93K (1)

−$249.93K

14,803

0.0086%

$434.28K

+404.4%

Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SEC

—

$245.02K (2)

−$245.02K

11,280

0.0065%

$330.93K

+598.5%

BAKER BROS. ADVISORS LP entity

Director

—

39,384,587

22.86%

$1.16B

+0.2%

Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

—

62,105

0.0360%

$1.82M

+18.1%

SOLAND DANIEL B

Director

—

44,041

0.0256%

$1.29M

+27.1%

HARRIGAN EDMUND

Director

—

43,148

0.0250%

$1.27M

+68.2%

GAROFALO ELIZABETH A.

Director

—

33,489

0.0194%

$982.48K

+48.7%

Ndu Adora

Director

—

32,908

0.0191%

$965.44K

+198.3%

Brege Laura

Director

—

23,202

0.0135%

$680.69K

+15.1%

Poole Jonathan

Director

—

2,010

0.0012%

$58.97K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Schneyer Mark C.

6 Aug 2026

EVP, CHIEF FINANCIAL OFFICER

Sold after exercise

9,292

$29.34

$272.60K

Schneyer Mark C.

6 Aug 2026

EVP, CHIEF FINANCIAL OFFICER

Sold after exercise

5,000

$29.00

$145.00K

Schneyer Mark C.

5 Aug 2026

EVP, CHIEF FINANCIAL OFFICER

Sold after exercise

5,849

$29.00

$169.64K

Thompson Elizabeth H.Z.

30 Jul 2026

EVP, Head of Research & Dev

Sell

$26.17

$1.31K

Thompson Elizabeth H.Z.

30 Jul 2026

EVP, Head of Research & Dev

Sell

16,508

$26.13

$431.35K

Kihara James

26 Jun 2026

PRINCIPAL ACCOUNTING OFFICER

Sold on a plan

11,421

$26.08

$297.91K

Kihara James

26 May 2026

PRINCIPAL ACCOUNTING OFFICER

Sell

5,401

$21.18

$114.39K

Schneyer Mark C.

4 May 2026

EVP, CHIEF FINANCIAL OFFICER

Sell

3,506

$21.79

$76.40K

Kihara James

4 May 2026

PRINCIPAL ACCOUNTING OFFICER

Sell

1,332

$21.79

$29.02K

Kihara James

7 Apr 2026

PRINCIPAL ACCOUNTING OFFICER

Sell

1,030

$22.20

$22.87K

Schneyer Mark C.

7 Apr 2026

EVP, CHIEF FINANCIAL OFFICER

Sell

2,709

$22.20

$60.14K

Schneyer Mark C.

26 Mar 2026

EVP, CHIEF FINANCIAL OFFICER

Sell

$21.72

$803.54

Schneyer Mark C.

26 Mar 2026

EVP, CHIEF FINANCIAL OFFICER

Sell

3,171

$21.65

$68.65K

Kihara James

26 Mar 2026

PRINCIPAL ACCOUNTING OFFICER

Sell

$21.73

$260.70

Kihara James

26 Mar 2026

PRINCIPAL ACCOUNTING OFFICER

Sell

1,097

$21.65

$23.75K

Schneyer Mark C.

25 Mar 2026

EVP, CHIEF FINANCIAL OFFICER

Sold after exercise

4,177

$21.47

$89.68K

Kihara James

25 Mar 2026

PRINCIPAL ACCOUNTING OFFICER

Sold after exercise

833

$21.47

$17.88K

Rhodes Jennifer J

25 Mar 2026

EVP, CHIEF LEGAL OFFICER, SEC

Sell

3,844

$21.47

$82.53K

Thompson Elizabeth H.Z.

25 Mar 2026

EVP, Head of Research & Dev

Sell

3,435

$21.47

$73.75K

Owen Adams Catherine

25 Mar 2026

Chief Executive Officer

Sell

11,641

$21.47

$249.93K

Rhodes Jennifer J

9 Feb 2026

EVP, CHIEF LEGAL OFFICER, SEC

Sell

6,950

$23.38

$162.49K

Kihara James

18 Nov 2025

PRINCIPAL ACCOUNTING OFFICER

Sell

4,084

$23.69

$96.75K

Schneyer Mark C.

18 Nov 2025

EVP, CHIEF FINANCIAL OFFICER

Sell

10,262

$23.69

$243.11K

Daly James M

10 Nov 2025

Director

Sell

30,000

$22.37

$670.98K

ACADIA PHARMACEUTICALS INC

By person

Individual transactions

What was left out